Rivaroxaban (Xarelto ) - Reminder That 15 MG and 20 MG Tablets Should Be Taken With Food - GOV - UK

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

18/7/2019 Rivaroxaban (Xarelto▼): reminder that 15 mg and 20 mg tablets should be taken with food - GOV.

UK

GOV.UK
1. Home (https://www.gov.uk/)
2. Drug Safety Update (https://www.gov.uk/drug-safety-update)

Rivaroxaban (Xarelto▼): reminder that 15 mg and 20


mg tablets should be taken with food
MHRA has received a small number of reports suggesting lack of efficacy (thromboembolic events) in patients
taking 15 mg or 20 mg rivaroxaban on an empty stomach; remind patients to take 15 mg or 20 mg rivaroxaban
tablets with food.

Published 17 July 2019

From:
Medicines and Healthcare products Regulatory Agency (https://www.gov.uk/government/organisations/medicines-
and-healthcare-products-regulatory-agency)

Therapeutic area:
Cardiovascular disease and lipidology (https://www.gov.uk/drug-safety-update?
therapeutic_area%5B%5D=cardiovascular-disease-lipidology), Haematology (https://www.gov.uk/drug-safety-update?
therapeutic_area%5B%5D=haematology)

Contents
Importance of taking rivaroxaban 15 mg and 20 mg tablets with food
Further information about rivaroxaban

Advice for healthcare professionals:


remind patients to take rivaroxaban 15 mg or 20 mg tablets with food
for patients who have difficulty swallowing, tablets can be crushed and mixed with water or apple puree
immediately before taking; this mixture should be immediately followed by food
rivaroxaban 2.5 mg and 10 mg tablets can be taken with or without food
report suspected adverse drug reactions, including any suspected events associated with lack of
efficacy to rivaroxaban, on a Yellow Card (https://yellowcard.mhra.gov.uk/)

Importance of taking rivaroxaban 15 mg and 20 mg tablets with food


Clinical trials of rivaroxaban showed that food intake does not affect absorption of 2.5 mg or 10 mg tablets, while
absorption of 20 mg tablets was optimal when taken with high-fat, high-calorie meal. For this reason, rivaroxaban
15 mg and 20 mg tablets are to be taken with food.

https://www.gov.uk/drug-safety-update/rivaroxaban-xarelto-reminder-that-15-mg-and-20-mg-tablets-should-be-taken-with-food 1/2
18/7/2019 Rivaroxaban (Xarelto▼): reminder that 15 mg and 20 mg tablets should be taken with food - GOV.UK

MHRA has received a small number of reports of patients taking rivaroxaban 15 mg or 20 mg who experienced a
thromboembolic event, which the reporter suspected was due to the patient taking the tablets on an empty
stomach.

The section of the Patient Information Leaflet for rivaroxaban 15 mg and 20 mg tablets that advises patients how
to take their medicine has been revised to emphasise patients must take rivaroxaban with a meal and the tablets
should be swallowed preferably with water.

Further information about rivaroxaban


Xarelto (https://www.medicines.org.uk/emc/product/2793/smpc) (rivaroxaban) is a direct inhibitor of coagulation factor
Xa with the following indications:

Co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine, for
prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with
elevated cardiac biomarkers (2.5 mg dose)
Co-administered with ASA, for the prevention of atherothrombotic events in adult patients with coronary
artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events (2.5
mg)
Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement
surgery (10 mg)
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or
more risk factors, such as congestive heart failure, hypertension, age of 75 years and older, diabetes
mellitus, prior stroke or transient ischaemic attack (15 mg and 20 mg)
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT
and PE in adults (10 mg, 15 mg, and 20 mg).

Article citation: Drug Safety Update volume 12, issue 12: July 2019: 3.

Published 17 July 2019

Explore the topic


Alerts and recalls (https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts-
alerts-and-recalls)

https://www.gov.uk/drug-safety-update/rivaroxaban-xarelto-reminder-that-15-mg-and-20-mg-tablets-should-be-taken-with-food 2/2

You might also like